NF-κB in Cellular Senescence and Cancer Treatment

  • Jing, Hua (MKFZ, Charite - Universitatsmedizin Berlin and Max-Delbruck-Centrum for Molecular Medicine) ;
  • Lee, Soyoung (MKFZ, Charite - Universitatsmedizin Berlin and Max-Delbruck-Centrum for Molecular Medicine)
  • Received : 2013.11.25
  • Accepted : 2013.11.28
  • Published : 2014.03.31


The NF-${\kappa}B$ pathway transcriptionally controls a large set of target genes that play important roles in cell survival, inflammation, and immune responses. While many studies showed anti-tumorigenic and pro-survival role of NF-${\kappa}B$ in cancer cells, recent findings postulate that NF-${\kappa}B$ participates in a senescence-associated cytokine response, thereby suggesting a tumor restraining role of NF-${\kappa}B$. In this review, we discuss implications of the NF-${\kappa}B$ signaling pathway in cancer. Particularly, we emphasize the connection of NF-${\kappa}B$ with cellular senescence as a response to chemotherapy, and furthermore, present examples how distinct oncogenic network contexts surrounding NF-${\kappa}B$ produce fundamentally different treatment outcomes in aggressive B-cell lymphomas as an example.


  1. Davis, R.E., Brown, K.D., Siebenlist, U., and Staudt, L.M. (2001). Constitutive nuclear factor kappa B activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells. J. Exp. Med. 194, 1861-1874.
  2. Huang, J.Z., Sanger, W.G., Greiner, T.C., Staudt, L.M., Weisenburger, D.D., Pickering, D.L., Lynch, J.C., Armitage, J.O., Warnke, R.A., Alizadeh, A.A., et al. (2002). The t(14;18) defines a unique subset of diffuse large B-cell lymphoma with a germinal center B-cell gene expression profile. Blood 99, 2285-2290.
  3. Inokuchi, S., Aoyama, T., Miura, K., Osterreicher, C.H., Kodama, Y., Miyai, K., Akira, S., Brenner, D.A., and Seki, E. (2010). Disruption of TAK1 in hepatocytes causes hepatic injury, inflammation, fibrosis, and carcinogenesis. Proc. Natl. Acad. Sci. USA 107, 844-849.
  4. Iqbal, J., Sanger, W.G., Horsman, D.E., Rosenwald, A., Pickering, D.L., Dave, B., Dave, S., Xiao, L., Cao, K., Zhu, Q., et al. (2004). BCL2 translocation defines a unique tumor subset within the germinal center B-cell-like diffuse large B-cell lymphoma. Am. J. Pathol. 165, 159-166.
  5. Kaltschmidt, B., Kaltschmidt, C., Hofmann, T.G., Hehner, S.P., Droge, W., and Schmitz, M.L. (2000). The pro- or anti-apoptotic function of NF-kappaB is determined by the nature of the apoptotic stimulus. Eur. J. Biochem. 267, 3828-3835.
  6. Coppe, J.P., Patil, C.K., Rodier, F., Sun, Y., Munoz, D.P., Goldstein, J., Nelson, P.S., Desprez, P.Y., and Campisi, J. (2008). Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol. 6, 2853-2868.
  7. Coppe, J.P., Desprez, P.Y., Krtolica, A., and Campisi, J. (2010). The senescence-associated secretory phenotype: the dark side of tumor suppression. Annu. Rev. Pathol. 5, 99-118.
  8. Franzoso, G., Bours, V., Park, S., Tomita-Yamaguchi, M., Kelly, K., and Siebenlist, U. (1992). The candidate oncoprotein Bcl-3 is an antagonist of p50/NF-$\kappa{B}$-mediated inhibition. Nature 359, 339-342.
  9. Guttridge, D.C., Albanese, C., Reuther, J.Y., Pestell, R.G., and Baldwin, A.S. Jr. (1999). NF-kappaB controls cell growth and differentiation through transcriptional regulation of cyclin D1. Mol. Cell. Biol. 19, 5785-5799.
  10. Grivennikov, S., Greten, F.R., and Karin, M. (2010). Immunity, inflammation, and cancer. Cell 140, 883-899.
  11. Hayden, M.S., and Ghosh, S. (2004). Signaling to NF-kappaB. Genes Dev. 18, 2195-2224.
  12. Hayden, M.S., and Ghosh, S. (2008). Shared principles in NF-kappaB signaling. Cell 132, 344-362.
  13. Heyninck, K., and Beyaert, R. (2005). A20 inhibits NF-$\kappa{B}$activation by dual ubiquitin-editing functions. Trends Biochem. Sci. 30, 1-4.
  14. Lim, K.H., Yang, Y., and Staudt, L.M. (2012). Pathogenetic importance and therapeutic implications of NF-$\kappa{B}$in lymphoid malignancies. Immunol. Rev. 246, 359-378.
  15. Lam, L.T., Davis, R.E., Pierce, J., Hepperle, M., Xu, Y., Hottelet, M., Nong, Y., Wen, D., Adams, J., Dang, L., et al. (2005). Small molecule inhibitors of IkappaB kinase are selectively toxic for subgroups of diffuse large B-cell lymphoma defined by gene expression profiling. Clin. Cancer Res. 11, 28-40.
  16. Lenz, G., Davis, R.E., Ngo, V.N., Lam, L., George, T.C., Wright, G. W., Dave, S.S., Zhao, H., Xu, W., Rosenwald, A., et al. (2008a). Oncogenic CARD11 mutations in human diffuse large B cell lymphoma. Science 319, 1676-1679.
  17. Lenz, G., Wright, G., Dave, S.S., Xiao, W., Powell, J., Zhao, H., Xu, W., Tan, B., Goldschmidt, N., Iqbal, J., et al. (2008b). Stromal gene signatures in large-B-cell lymphomas. N. Engl. J. Med. 359, 2313-232.
  18. Luedde, T., Beraza, N., Kotsikoris, V., van Loo, G., Nenci, A., De Vos, R., Roskams, T., Trautwein, C., and Pasparakis, M. (2007). Deletion of NEMO/IKKgamma in liver parenchymal cells causes steatohepatitis and hepatocellular carcinoma. Cancer Cell 11, 119-132.
  19. Maeda, S., Kamata, H., Luo, J.L., Leffert, H., and Karin, M. (2005). IKK couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis. Cell 121, 977-990.
  20. Martin, A.G., Trama, J., Crighton, D., Ryan, K.M., and Fearnhead, H.O. (2009). Activation of p73 and induction of Noxa by DNA damage requires NF-kappa B. Aging 1, 335-349.
  21. Compagno, M., Lim, W.K., Grunn, A., Nandula, S.V., Brahmachary, M., Shen, Q., Bertoni, F., Ponzoni, M., Scandurra, M., Califano, A., et al. (2009). Mutations of multiple genes cause deregulation of NF-kappaB in diffuse large B-cell lymphoma. Nature 459, 717-721.
  22. Keats, J.J., Fonseca, R., Chesi, M., Schop, R., Baker, A., Chng, W.J., Van Wier, S., Tiedemann, R., Shi, C.X., Sebag, M., et al. (2007). Promiscuous mutations activate the noncanonical NF-$\kappa{B}$pathway in multiple myeloma. Cancer Cell 12, 131-144.
  23. Schneider, A., Martin-Villalba, A., Weih, F., Vogel, J., Wirth, T., and Schwaninger, M. (1999). NF-kappaB is activated and promotes cell death in focal cerebral ischemia. Nat. Med. 5, 554-559.
  24. Seitz, C.S., Lin, Q., Deng, H., and Khavari, P.A. (1998). Alterations in NF-$\kappa{B}$function in transgenic epithelial tissue demonstrate a growth inhibitory role for NF-$\kappa{B}$. Proc. Natl. Acad. Sci. USA 95, 2307-2312.
  25. Kasibhatla, S., Genestier, L., and Green, D.R. (1999). Regulation of fas-ligand expression during activation-induced cell death in T lymphocytes via nuclear factor kappaB. J. Biol. Chem. 274, 987-992.
  26. Keller, U., Huber, J., Nilsson, J.A., Fallahi, M., Hall, M.A., Peschel, C., and Cleveland, J.L. (2010). Myc suppression of Nfkb2 accelerates lymphomagenesis. BMC Cancer 10, 348.
  27. Kortlever, R.M., Higgins, P.J., and Bernards, R. (2006). Plasminogen activator inhibitor-1 is a critical downstream target of p53 in the induction of replicative senescence. Nat. Cell Biol. 8, 877-884.
  28. Kuilman, T., and Peeper, D.S. (2009). Senescence-messaging secretome: SMS-ing cellular stress. Nat. Rev. Cancer 9, 81-94.
  29. Kuilman, T., Michaloglou, C., Vredeveld, L.C., Douma, S., van Doorn, R., Desmet, C.J., Aarden, L.A., Mooi, W.J., and Peeper, D.S. (2008). Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network. Cell 133, 1019-1031.
  30. Kuilman, T., Michaloglou, C., Mooi, W.J., and Peeper, D.S. (2010). The essence of senescence. Genes Dev. 24, 2463-2479.
  31. Rosenwald, A., Wright, G., Chan, W.C., Connors, J.M., Campo, E., Fisher, R.I., Gascoyne, R.D., Muller-Hermelink, H.K., Smeland, E.B., Giltnane, J.M., et al. (2002). The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N. Engl. J. Med. 346, 1937-1947.
  32. Popivanova, B.K., Kitamura, K., Wu, Y., Kondo, T., Kagaya, T., Kaneko, S., Oshima, M., Fujii, C., and Mukaida, N. (2008). Blocking TNF-alpha in mice reduces colorectal carcinogenesis associated with chronic colitis. J. Clin. Invest. 118, 560-570.
  33. Prasad, S., Ravindran, J., and Aggarwal, B.B. (2010). NF-kappaB and cancer: how intimate is this relationship. Mol. Cell. Biochem. 336, 25-37.
  34. Reimann, M., Lee, S., Loddenkemper, C., Dorr, J.R., Tabor, V., Aichele, P., Stein, H., Dorken, B., Jenuwein, T., and Schmitt, C. A. (2010). Tumor stroma-derived TGF-beta limits myc-driven lymphomagenesis via Suv39h1-dependent senescence. Cancer Cell. 17, 262-272.
  35. Rovillain, E., Mansfield, L., Caetano, C., Alvarez-Fernandez, M., Caballero, O.L., Medema, R.H., Hummerich, H., and Jat, P.S. (2011). Activation of nuclear factor-kappa B signalling promotes cellular senescence. Oncogene 30, 2356-2366.
  36. Ryan, K.M., Ernst, M.K., Rice, N.R., and Vousden, K.H. (2000). Role of NF-kappaB in p53-mediated programmed cell death. Nature 404, 892-897.
  37. Schmitt, C.A. (2007). Cellular senescence and cancer treatment. Biochim. Biophys. Acta 1775, 5-20.
  38. Schmitt, C.A., Fridman, J.S., Yang, M., Lee, S., Baranov, E., Hoffman, R.M., and Lowe, S.W. (2002). A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy. Cell 109, 335-346.
  39. Sheehy, A.M., and Schlissel, M.S. (1999). Overexpression of RelA causes G1 arrest and apoptosis in a Pro-B cell line. J. Biol. Chem. 274, 8708-8716.
  40. Yamamoto, K., Arakawa, T., Ueda, N., and Yamamoto, S. (1995). Transcriptional roles of nuclear factor kappa B and nuclear factor-interleukin-6 in the tumor necrosis factor alpha-dependent induction of cyclooxygenase-2 in MC3T3-E1 cells. J. Biol. Chem. 270, 31315-31320.
  41. Yang, J., Splittgerber, R., Yull, F.E., Kantrow, S., Ayers, G.D., Karin, M., and Richmond, A. (2010). Conditional ablation of Ikk$\beta$ inhibits melanoma tumor development in mice. J. Clin. Invest. 120, 2563-2574.
  42. Sen, R., and Baltimore, D. (1986). Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell 46, 705-716.
  43. Neri, A., Chang, C.C., Lombardi, L., Salina, M., Corradini, P., Maiolo, AT., Chaganti, R.S., and Dalla-Favera, R. (1991). B cell lymphoma-associated chromosomal translocation involves candidate oncogene lyt-10, homologous to NF-$\kappa{B}$p50. Cell 67, 1075-1087.
  44. Ngo, V.N., Davis, R.E., Lamy, L., Yu, X., Zhao, H., Lenz, G., Lam, L.T., Dave, S., Yang, L., Powell, J., et al. (2006). A loss-offunction RNA interference screen for molecular targets in cancer. Nature 441, 106-110.
  45. Ngo, V.N., Young, R.M., Schmitz, R., Jhavar, S., Xiao, W., Lim, K.H., Kohlhammer, H., Xu, W., Yang, Y., Zhao, H., et al. (2011). Oncogenically active MYD88 mutations in human lymphoma. Nature 470, 115-119.
  46. Perkins, N.D. (2007). Integrating cell-signalling pathways with NFkappaB and IKK function. Nat. Rev. Mol. Cell Biol. 8, 49-62.
  47. Wang, C.Y., Mayo, M.W., Korneluk, R.G., Goeddel, D.V., and Baldwin, A.S. Jr. (1998). NF-$\kappa{B}$antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science 281, 1680-1683.
  48. Sun, L., Deng, L., Ea, C.K., Xia, Z.P., and Chen, Z.J. (2004). The TRAF6 ubiquitin ligase and TAK1 kinase mediate IKK activation by BCL10 and MALT1 in T lymphocytes. Mol. Cell 14, 289-301.
  49. Tamatani, M., Che, Y.H., Matsuzaki, H., Ogawa, S., Okado, H., Miyake, S., Mizuno, T., and Tohyama, M. (1999). Tumor necrosis factor induces Bcl-2 and Bcl-x expression through NFkappaB activation in primary hippocampal neurons. J. Biol. Chem. 274, 8531-8538.
  50. te Poele, R.H., Okorokov, A.L., Jardine, L., Cummings, J., and Joel, S.P. (2002). DNA damage is able to induce senescence in tumor cells in vitro and in vivo. Cancer Res. 62, 1876-1883.
  51. Tu, S., Bhagat, G., Cui, G., Takaishi, S., Kurt-Jones, E.A., Rickman, B., Betz, K.S., Penz-Oesterreicher, M., Bjorkdahl, O., Fox, J.G., et al. (2008). Overexpression of interleukin-1beta induces gastric inflammation and cancer and mobilizes myeloid-derived suppressor cells in mice. Cancer Cell 14, 408-419.
  52. Wertz, I.E., O'Rourke, K.M., Zhou, H., Eby, M., Aravind, L., Seshagiri, S., Wu, P., Wiesmann, C., Baker, R., Boone, D.L., et al. (2004). De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-$\kappa{B}$signalling. Nature 430, 694-699.
  53. Xue, W., Zender, L., Miething, C., Dickins, R.A., Hernando, E., Krizhanovsky, V., Cordon-Cardo, C., and Lowe, S.W. (2007). Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas. Nature 445, 656-660.
  54. Chang, B.D., Broude, E.V., Dokmanovic, M., Zhu, H., Ruth, A., Xuan, Y., Kandel, ES., Lausch, E., Christov, K., and Roninson, I.B. (1999). A senescence-like phenotype distinguishes tumor cells that undergo terminal proliferation arrest after exposure to anticancer agents. Cancer Res. 59, 3761-3767.
  55. Braig, M., Lee, S., Loddenkemper, C., Rudolph, C., Peters, A.H., Schlegelberger, B., Stein, H., Dorken, B., Jenuwein, T., and Schmitt, C.A. (2005) Oncogene-induced senescence as an initial barrier in lymphoma development. Nature 436, 660-665.
  56. Calado, D.P., Zhang, B., Srinivasan, L., Sasaki, Y., Seagal, J., Unitt, C., Rodig, S., Kutok, J., Tarakhovsky, A., Schmidt-Supprian, M., et al. (2010). Constitutive canonical NF-$\kappa{B}$activation cooperates with disruption of BLIMP1 in the pathogenesis of activated B cell-like diffuse large cell lymphoma. Cancer Cell 18, 580-589.
  57. Catz, S.D., and Johnson, J.L. (2001). Transcriptional regulation of bcl-2 by nuclear factor kappa B and its significance in prostate cancer. Oncogene 20, 7342-7351.
  58. Zhou, H., Wertz, I., O'Rourke, K., Ultsch, M., Seshagiri, S., Eby, M., Xiao, W., and Dixit, V.M. (2004). Bcl10 activates the NF-kappaB pathway through ubiquitination of NEMO. Nature 427, 167-171.
  59. Zhu, L., Fukuda, S., Cordis, G., Das, D.K., and Maulik, N. (2001). Anti-apoptotic protein surviving plays a significant role in tubular morphogenesis of human coronary arteriolar endothelial cells by hypoxic preconditioning. FEBS Lett. 508, 369-374.
  60. Staudt, L.M. (2010). Oncogenic activation of NF-$\kappa{B}$. Cold Spring Harb Perspect Biol. 2, a000109.
  61. Stehlik, C., de Martin. R., Kumabashiri, I., Schmid, J.A., Binder, B.R., and Lipp, J. (1998). Nuclear factor (NF)-kappaB-regulated X-chromosome-linked iap gene expression protects endothelial cells from tumor necrosis factor alpha-induced apoptosis. J. Exp. Med. 188, 211-216.
  62. Arkan, M.C., and Greten, F.R. (2011). IKK- and NF-$\kappa{B}$-mediated functions in carcinogenesis. Curr. Top. Microbiol. Immunol. 349, 159-169.
  63. Annunziata, C.M., Davis, R.E., Demchenko, Y., Bellamy, W., Gabrea, A., Zhan, F., Lenz, G., Hanamura, I., Wright, G., Xiao, W., et al. (2007). Frequent engagement of the classical and alternative NF-$\kappa{B}$pathways by diverse genetic abnormalities in multiple myeloma. Cancer Cell 12, 115-130.
  64. Acosta, J.C., O'Loghlen, A., Banito, A., Guijarro, M.V., Augert, A., Raguz, S., Fumagalli, M., Da Costa, M., Brown, C., Popov, N., et al. (2008). Chemokine Signaling via the CXCR2 Receptor Reinforces Senescence. Cell 133, 1006-1018.
  65. Alizadeh, A.A., Eisen, M.B., Davis, R.E., Ma, C., Lossos, I.S., Rosenwald, A., Boldrick, J.C., Sabet, H., Tran, T., Yu, X., et al. (2000). Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403, 503-511.
  66. Baldwin, A.S. (2001). Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB. J. Clin. Invest. 107, 241-246.
  67. Basseres, D.S., and Baldwin, A.S. (2006). Nuclear factor-kappaB and inhibitor of kappaB kinase pathways in oncogenic initiation and progression. Oncogene 25, 6817-6830.
  68. Basseres, D.S., Ebbs, A., Levantini, E., and Baldwin, A.S. (2010). Requirement of the NF-$\kappa{B}$subunit p65/RelA for K-Ras-induced lung tumorigenesis. Cancer Res. 70, 3537-354.
  69. Ben-Neriah, Y., and Karin, M. (2011). Inflammation meets cancer, with NF-$\kappa{B}$as the matchmaker. Nat. Immunol. 12, 715-723.
  70. Bonizzi, G., and Karin, M. (2004). The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends Immunol. 25, 280-288.

Cited by

  1. Effects of probucol on cell proliferation in human ovarian cancer cells vol.5, pp.1, 2016,
  2. Effect of Pomegranate Hull Extract on Liver Neoplastic Changes in Rats: More than an Antioxidant vol.68, pp.6, 2016,
  3. TMPRSS4 promotes invasiveness of human gastric cancer cells through activation of NF-κB/MMP-9 signaling vol.77, 2016,
  4. Immune System Dysfunction in the Elderly vol.89, pp.1, 2017,
  5. Elucidation of Altered Pathways in Tumor-Initiating Cells of Triple-Negative Breast Cancer: A Useful Cell Model System for Drug Screening vol.35, pp.8, 2017,
  6. Farnesoid X receptor signal is involved in deoxycholic acid-induced intestinal metaplasia of normal human gastric epithelial cells vol.34, pp.5, 2015,
  7. Mutant DD genotype of NFKB1 gene is associated with the susceptibility and severity of coronary artery disease vol.103, 2017,
  8. Translational Horizons in the Tumor Microenvironment: Harnessing Breakthroughs and Targeting Cures vol.35, pp.2, 2015,
  9. The role of NF-κB in PARP-inhibitor-mediated sensitization and detoxification of arsenic trioxide in hepatocellular carcinoma cells vol.40, pp.3, 2015,
  10. Induction of IκB-ζ by Epstein-Barr virus latent membrane protein-1 and CD30 vol.47, pp.6, 2015,
  11. Metabolomics–Proteomics Combined Approach Identifies Differential Metabolism-Associated Molecular Events between Senescence and Apoptosis vol.16, pp.6, 2017,
  12. The PPARγ-SETD8 axis constitutes an epigenetic, p53-independent checkpoint on p21-mediated cellular senescence vol.16, pp.4, 2017,
  13. Emerging prognostic markers related to mesenchymal characteristics of poorly differentiated breast cancers vol.37, pp.4, 2016,
  14. Investigation of nutriactive phytochemical - gamma-oryzanol in experimental animal models vol.100, pp.4, 2016,
  15. Cobrotoxin fromNaja naja atraVenom Ameliorates Adriamycin Nephropathy in Rats vol.2015, 2015,
  16. Sorafenib effect on liver neoplastic changes in rats: more than a kinase inhibitor vol.17, pp.2, 2017,
  17. PM2.5 obtained from urban areas in Beijing induces apoptosis by activating nuclear factor-kappa B vol.4, pp.1, 2017,
  18. UBXD Proteins: A Family of Proteins with Diverse Functions in Cancer vol.17, pp.10, 2016,
  19. Upregulation of microRNA-181b inhibits CCL18-induced breast cancer cell metastasis and invasion via the NF-κB signaling pathway vol.12, pp.6, 2016,
  20. Anti-inflammatory Activity of Tocotrienols in Age-related Pathologies: A SASPected Involvement of Cellular Senescence vol.20, pp.1, 2018,
  21. NF-κB Signaling in Targeting Tumor Cells by Oncolytic Viruses—Therapeutic Perspectives vol.10, pp.11, 2018,
  22. Exacerbated Apoptosis of Cells Infected with Infectious Bursal Disease Virus upon Exposure to Interferon Alpha vol.92, pp.11, 2018,
  23. NF-κB, inflammation, immunity and cancer: coming of age vol.18, pp.5, 2018,
  24. Essential Roles for the Non-Canonical IκB Kinases in Linking Inflammation to Cancer, Obesity, and Diabetes vol.8, pp.2, 2019,